Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Atrium Therapeutics, Inc.NASDAQ: RNA

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin at 99.2%

Gross margin was 99.2% in Q1 FY2026.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
99.2%-0.8 pp QoQ
Last fiscal yearDec 2025
100.0%— YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
100.0%
Year-over-year change
—

Gross Margin vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Gross Margin figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.